Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012:2012:425021.
doi: 10.1155/2012/425021. Epub 2011 Nov 14.

Induction of immunological tolerance by oral anti-CD3

Andre Pires da Cunha  1 , Howard L Weiner
Affiliations
Review

Induction of immunological tolerance by oral anti-CD3

Andre Pires da Cunha et al. Clin Dev Immunol. 2012.

Abstract

In recent years, our knowledge about immunoregulation and autoimmunity has significantly advanced, but nontoxic and more effective treatments for different inflammatory and autoimmune diseases are still lacking. Oral tolerance is of unique immunologic importance because it is a continuous natural immunologic event driven by exogenous antigen and is an attractive approach for treatment of these conditions. Parenteral administration of anti-CD3 monoclonal antibody is an approved therapy for transplantation in humans and is effective in autoimmune diabetes. Orally administered anti-CD3 monoclonal antibody is biologically active in the gut and suppresses experimental models of autoimmune diseases. Orally delivered antibody does not have side effects including cytokine release syndromes, thus oral anti-CD3 antibody is clinically applicable for chronic therapy. Here we review findings that identify a novel and powerful immunologic approach that is widely applicable for the treatment of human autoimmune conditions.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunological Reviews. 2011;241(1):241–259. - PMC - PubMed
    1. Vaz NM, Maia LCS, Hanson DG, Lynch JM. Inhibition of homocytotropic antibody responses in adult inbred mice by previous feeding of the specific antigen. Journal of Allergy and Clinical Immunology. 1977;60(2):110–115. - PubMed
    1. Faria AMC, Weiner HL. Oral tolerance: therapeutic implications for autoimmune diseases. Clinical and Developmental Immunology. 2006;13(2-4):143–157. - PMC - PubMed
    1. Strobel S, Mowat AM. Oral tolerance and allergic responses to food proteins. Current Opinion in Allergy and Clinical Immunology. 2006;6(3):207–213. - PubMed
    1. Chen Y, Inobe JI, Kuchroo VK, Baron JL, Janeway CA, Weiner HL. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(1):388–391. - PMC - PubMed

LinkOut - more resources